SlideShare a Scribd company logo
Session 11:
Process Improvement
Dr. Shree Baboolal
2/4/2023 1
Process Improvement – Role in QMS
• Process Improvement –
establishes a program for helping
to ensure continual improvement
in the lab over time.
• Continual improvement of the lab
processes is essential in a QMS.
2/4/2023 Infectious Disease Detection and Surveillance (IDDS) 2
W. Edward Deming
• Guru of Process Improvement.
• Deming Plan-Do-Check-Act
(PDCA) shows how to achieve
continual improvement in any
process.
2/4/2023 Infectious Disease Detection and Surveillance (IDDS) 3
PDCA
• Plan –
• Identify the problems and the
potential sources of system weakness
or error.
• Decide on the steps to be used to
gather information.
• Ask the question “How can you best
assess the current situation and
analyze root causes of problem areas?”
• Using the information that is gathered
through these techniques, develop a
plan for improvement.
• Do –
• Implement whatever plans
have been developed.
• Put the plan in action.
2/4/2023 Infectious Disease Detection and Surveillance (IDDS) 4
PDCA
• Check –
• Refers to the monitoring process.
• It is important to assess the
effectiveness of the actions taken.
• This is done using focused review
and audit process.
• After checking, revise the plan as
required to achieve the
improvements needed.
• Act –
• Take any corrective action that is
required and then recheck to be
sure that the solution has worked.
• This cycle is a continuous process,
so the lab will begin again with a
planning process to continue the
improvements.
2/4/2023 Infectious Disease Detection and Surveillance (IDDS) 5
ISO 15189 and Continual Improvements
• Activities for achieving continual improvements in the laboratory:
• Identify potential sources of any system weakness or error.
• Develop plans to implement improvement
• Implement the plan
• Review the effectiveness of the action through the process of focused review
and audit.
• Adjust the action plan and modify the system in accordance with the review
and adjust results.
2/4/2023 Infectious Disease Detection and Surveillance (IDDS) 6
What is Process Improvement?
• What is process improvement?
• Systematic and periodic approach to improving lab quality.
• In the lab patient samples are turned into results through processes.
• In process improvement – these processes are reviewed and improved to
ensure quality.
2/4/2023 Infectious Disease Detection and Surveillance (IDDS) 7
Tools for Process Improvement
• Internal and External Audits
• Identify system weakness and problem areas.
• Participation in EQA
• Allows for comparing laboratory performance to that of other laboratories.
• Management Review
• Reviews of records such as QC, inventory management, equipment
managements etc.
• Review of Quality Indicators
• Customer complaints, TATs, errors etc.
2/4/2023 Infectious Disease Detection and Surveillance (IDDS) 8
Quality Indicators
• Established measures used to determine how well an organization
meets needs and operational performance expectations.
• ISO15189 states that the lab SHALL implement quality indicators to
systematically monitor and evaluate the lab’s contribution to patient
care.
• When OFIs are identified the lab management SHALL address them
regardless of where they occur.
• ISO 15189 also states that labs participate in quality improvement
activities that deals with patient care.
2/4/2023 Infectious Disease Detection and Surveillance (IDDS) 9
Quality Indicators
• Quality Indicators are information that is measured. The indicators:
• Give information about the performance of a process
• Determine quality of service
• Highlight potential quality concerns
• Identify areas that need further study and investigation
• Track changes over time.
2/4/2023 Infectious Disease Detection and Surveillance (IDDS) 10
Selecting quality indicators
• Fewer are better.
• Too many may make it difficult to track
• Link the indicators to the factors needed for success.
• Choose the quality indicators that relate to areas that need correction in
order to achieve good performance.
• Select those that will be most meaningful to the laboratory.
• Indicators should be around customers and stakeholders needs.
2/4/2023 Infectious Disease Detection and Surveillance (IDDS) 11
Selecting Quality Indicators
• Measures should look at all levels of the laboratory.
• Include indicators that will evaluate function at the top management level,
but also flow down to all levels of employees.
• Measures should change as the environment and strategy changes.
• Do not stick with the same indicators over long periods of time.
• Base the targets and goals for the measures on rational values, rather
than values of convenience.
• They should be established on the basis of research rather than arbitrary
estimates.
2/4/2023 Infectious Disease Detection and Surveillance (IDDS) 12
Developing Successful Quality Indicators
• When developing successful quality indicators, ensure the following:
• Objective:
• Indicators should be measurable – usually in % or numbers e.g. contamination rate >2%
• Should not depend on subjective judgements
• Concrete evidence that the event occurred or not – e.g. number of errors
• The target is clearly met – e.g. if the target for successful PT is 80% or more.
• Methodology available:
• Be sure that the organization has the tools needed to accomplish the necessary
measurements.
• The laboratory must have the ability to gather the information.
• If the data or information collection requires special equipment, then make sure the
special equipment is available before starting.
2/4/2023 Infectious Disease Detection and Surveillance (IDDS) 13
Developing Successful Quality Indicators
• When developing successful quality indicators, ensure the following:
• Limits:
• The laboratory will need to know the acceptable value before starting measurements.
• Determine in advance the limits of acceptability, and at what point a result causes
concern.
• Also consider what action will be required. For example, how many delayed reports per
month would be considered acceptable? How many would be considered as requiring
corrective actions? How many would require immediate revision of the action plan?
• Interpretation:
• Decisions must be made as to how indicator information will be interpreted before
beginning measurements.
• Know in advance how to interpret the information that has been collected. For example,
if you are monitoring completed requisitions to see if they are correct, you need to know
how many samples you have examined, if they have come from multiple sources or all
sources, and whether they are for only one type of sample or all sample types.
2/4/2023 Infectious Disease Detection and Surveillance (IDDS) 14
Developing Successful Quality Indicators
• When developing successful quality indicators, ensure the following:
• Limitation:
• The organization should understand exactly what information is being provided by the
indicator, and be clear on what is not being determined by the measurement of a particular
indicator.
• For example, if collecting the number of accidents or errors, do you know if all are being
reported?
• Presentation:
• The organization must decide how to present the information in order to fully display its
value.
• Some information is best presented in a table, whereas other information might be best
shown by a longitudinal graphic bar or in text.
• Presentation of information is important when looking for trends that predict future
outcome.
2/4/2023 Infectious Disease Detection and Surveillance (IDDS) 15
Developing Successful Quality Indicators
• When developing successful quality indicators, ensure the following:
• Action Plan:
• Before beginning the use of an indicator, the laboratory should have some idea of what
to do if the indicator shows that there is a problem.
• Also decide how to collect the information, who will collect it, and how long it will be
collected.
• Exit Plan:
• Because making these measurements takes time and resources, there should be a plan
as to when to stop using a particular indicator and replace it with another.
• Generally, this is done when the original indicator shows that the operation is working
and stable.
2/4/2023 Infectious Disease Detection and Surveillance (IDDS) 16
Characteristics of Good QIs
• Measurable – evidence can be gathered and counted.
• Achievable – the lab has the capacity to gather the evidence
• Interpretable – information can be used to make decisions
• Actionable – it is possible to do something about it
• Balanced – in all phases of testing
• Engaging – should examine work of all staff and not just selected staff
• Timed – consider short and long term implications
2/4/2023 Infectious Disease Detection and Surveillance (IDDS) 17
Common Indicators tracked
2/4/2023 Infectious Disease Detection and Surveillance (IDDS) 18
Implementing Process Improvements
• Essential factors and steps:
• Commitment from all levels of the lab staff.
• Careful planning so that goals can be achieved.
• An organizational structure that supports process improvements.
• Leadership.
• Engagement of the people who normally do the tests
2/4/2023 Infectious Disease Detection and Surveillance (IDDS) 19
Quality Improvement Activities
• Use a timeline and do not take on more than can be accomplished
within a timeframe.
• Use a team approach involving bench level staff.
• Use appropriate quality improvement tools.
• Implement corrective and preventive actions.
• Report quality improvement findings and corrective action progress
to management and staff.
2/4/2023 Infectious Disease Detection and Surveillance (IDDS) 20

More Related Content

What's hot

Lecture 2 diagnostic molecular microbiology bls
Lecture 2 diagnostic molecular microbiology blsLecture 2 diagnostic molecular microbiology bls
Lecture 2 diagnostic molecular microbiology blsBruno Mmassy
 
Tb presentation lab diagosis sept 2013
Tb presentation lab diagosis  sept  2013Tb presentation lab diagosis  sept  2013
Tb presentation lab diagosis sept 2013
unittbjknphg
 
Quality Control
Quality ControlQuality Control
Quality Control
Dr. Aryan (Anish Dhakal)
 
Laboratory biosafety levels and transfer of biological samples
Laboratory biosafety levels and transfer of biological samplesLaboratory biosafety levels and transfer of biological samples
Laboratory biosafety levels and transfer of biological samples
Mintah Dadzie Francis
 
5. Paracoccidioidomyces.pptx
5. Paracoccidioidomyces.pptx5. Paracoccidioidomyces.pptx
5. Paracoccidioidomyces.pptx
Yadav Raj
 
15. lab diagnosis of hiv
15. lab diagnosis of hiv15. lab diagnosis of hiv
15. lab diagnosis of hiv
Dr SANTHIPRIYA GOPASANA
 
Validation of qualitative lab test methods
Validation of qualitative lab test  methods Validation of qualitative lab test  methods
Validation of qualitative lab test methods
Mostafa Mahmoud
 
Validation of lab instruments and quantitative test methods
Validation of lab instruments and quantitative test methods Validation of lab instruments and quantitative test methods
Validation of lab instruments and quantitative test methods
Mostafa Mahmoud
 
Laboratory accreditation by iso 15189
Laboratory accreditation by iso 15189Laboratory accreditation by iso 15189
Laboratory accreditation by iso 15189
CHRISTIAN MEDICAL COLLEGE AND HOSPITAL
 
Bacteriocin and its typing
Bacteriocin and its typingBacteriocin and its typing
Bacteriocin and its typingShyam Mishra
 
Medical Microbiology Case discussions
Medical Microbiology Case discussionsMedical Microbiology Case discussions
Medical Microbiology Case discussions
Suprakash Das
 
Lab safety
Lab safetyLab safety
Lab safetyitsebo
 
Laboratory accreditation
Laboratory accreditationLaboratory accreditation
Laboratory accreditation
Gift Sam
 
Specimen collection in mycology
Specimen collection in  mycology Specimen collection in  mycology
Specimen collection in mycology
Meenakshi Muthuswamy
 
Good clinical laboratory practices
Good clinical laboratory practicesGood clinical laboratory practices
Good clinical laboratory practices
Vamsi kumar
 
Toxoplasmosis
ToxoplasmosisToxoplasmosis
Toxoplasmosis
Fredy RS Gutierrez
 
Immunochromatographic assays
Immunochromatographic assaysImmunochromatographic assays
Immunochromatographic assays
Dr. Amer Ali Khaleel /HMU
 
Understanding Hiv Diagnostics And Lab Tests
Understanding Hiv Diagnostics And Lab TestsUnderstanding Hiv Diagnostics And Lab Tests
Understanding Hiv Diagnostics And Lab Tests
arthur_smith
 
SUBCUTANEOUS AND FUNGAL INFECTIONS
SUBCUTANEOUS AND FUNGAL INFECTIONSSUBCUTANEOUS AND FUNGAL INFECTIONS
SUBCUTANEOUS AND FUNGAL INFECTIONS
Ajeet Singh
 
Deadly Black Fungus In COVID-19 Patients In India
Deadly Black Fungus In COVID-19 Patients In IndiaDeadly Black Fungus In COVID-19 Patients In India
Deadly Black Fungus In COVID-19 Patients In India
Sushil Patel
 

What's hot (20)

Lecture 2 diagnostic molecular microbiology bls
Lecture 2 diagnostic molecular microbiology blsLecture 2 diagnostic molecular microbiology bls
Lecture 2 diagnostic molecular microbiology bls
 
Tb presentation lab diagosis sept 2013
Tb presentation lab diagosis  sept  2013Tb presentation lab diagosis  sept  2013
Tb presentation lab diagosis sept 2013
 
Quality Control
Quality ControlQuality Control
Quality Control
 
Laboratory biosafety levels and transfer of biological samples
Laboratory biosafety levels and transfer of biological samplesLaboratory biosafety levels and transfer of biological samples
Laboratory biosafety levels and transfer of biological samples
 
5. Paracoccidioidomyces.pptx
5. Paracoccidioidomyces.pptx5. Paracoccidioidomyces.pptx
5. Paracoccidioidomyces.pptx
 
15. lab diagnosis of hiv
15. lab diagnosis of hiv15. lab diagnosis of hiv
15. lab diagnosis of hiv
 
Validation of qualitative lab test methods
Validation of qualitative lab test  methods Validation of qualitative lab test  methods
Validation of qualitative lab test methods
 
Validation of lab instruments and quantitative test methods
Validation of lab instruments and quantitative test methods Validation of lab instruments and quantitative test methods
Validation of lab instruments and quantitative test methods
 
Laboratory accreditation by iso 15189
Laboratory accreditation by iso 15189Laboratory accreditation by iso 15189
Laboratory accreditation by iso 15189
 
Bacteriocin and its typing
Bacteriocin and its typingBacteriocin and its typing
Bacteriocin and its typing
 
Medical Microbiology Case discussions
Medical Microbiology Case discussionsMedical Microbiology Case discussions
Medical Microbiology Case discussions
 
Lab safety
Lab safetyLab safety
Lab safety
 
Laboratory accreditation
Laboratory accreditationLaboratory accreditation
Laboratory accreditation
 
Specimen collection in mycology
Specimen collection in  mycology Specimen collection in  mycology
Specimen collection in mycology
 
Good clinical laboratory practices
Good clinical laboratory practicesGood clinical laboratory practices
Good clinical laboratory practices
 
Toxoplasmosis
ToxoplasmosisToxoplasmosis
Toxoplasmosis
 
Immunochromatographic assays
Immunochromatographic assaysImmunochromatographic assays
Immunochromatographic assays
 
Understanding Hiv Diagnostics And Lab Tests
Understanding Hiv Diagnostics And Lab TestsUnderstanding Hiv Diagnostics And Lab Tests
Understanding Hiv Diagnostics And Lab Tests
 
SUBCUTANEOUS AND FUNGAL INFECTIONS
SUBCUTANEOUS AND FUNGAL INFECTIONSSUBCUTANEOUS AND FUNGAL INFECTIONS
SUBCUTANEOUS AND FUNGAL INFECTIONS
 
Deadly Black Fungus In COVID-19 Patients In India
Deadly Black Fungus In COVID-19 Patients In IndiaDeadly Black Fungus In COVID-19 Patients In India
Deadly Black Fungus In COVID-19 Patients In India
 

Similar to Module 11 Process Improvement.pptx

EMIS
EMIS EMIS
ME_Katende (2).ppt
ME_Katende (2).pptME_Katende (2).ppt
ME_Katende (2).ppt
ShriAnveshaDasari
 
Assessment MEAL Frameworks in scientific field.ppt
Assessment MEAL Frameworks in scientific field.pptAssessment MEAL Frameworks in scientific field.ppt
Assessment MEAL Frameworks in scientific field.ppt
ShahidMahmood503398
 
Qi toolkit oct 2020
Qi toolkit oct 2020 Qi toolkit oct 2020
Qi toolkit oct 2020
JosephCope3
 
9 Quality Management System_EAT G H 2021.pptx
9 Quality Management System_EAT G H 2021.pptx9 Quality Management System_EAT G H 2021.pptx
9 Quality Management System_EAT G H 2021.pptx
Nagaraju94925
 
Quality assurance
Quality assuranceQuality assurance
Quality assurance
RijoLijo
 
monitoring and evaluation
monitoring and evaluationmonitoring and evaluation
monitoring and evaluation
Tarek Sallam
 
Unit IV_Monitoring_and_Evaluation.pptx
Unit IV_Monitoring_and_Evaluation.pptxUnit IV_Monitoring_and_Evaluation.pptx
Unit IV_Monitoring_and_Evaluation.pptx
MusondaMofu2
 
Quality assurance
Quality assuranceQuality assurance
Quality assurance
Nabin Lamichhane
 
PLCO_Indicators_0606.pptx
PLCO_Indicators_0606.pptxPLCO_Indicators_0606.pptx
PLCO_Indicators_0606.pptx
Afrim Alili
 
Auditing for Sterile Production Area
Auditing for Sterile Production AreaAuditing for Sterile Production Area
Auditing for Sterile Production Area
MANIKANDAN V
 
Monitoring Scale-up of Health Practices and Interventions
Monitoring Scale-up of Health Practices and InterventionsMonitoring Scale-up of Health Practices and Interventions
Monitoring Scale-up of Health Practices and Interventions
MEASURE Evaluation
 
Controlling ppt
Controlling  pptControlling  ppt
Controlling ppt
MaglinAnusha1
 
6_Kimberly Todd - QA and QC.pptx
6_Kimberly Todd - QA and QC.pptx6_Kimberly Todd - QA and QC.pptx
6_Kimberly Todd - QA and QC.pptx
JoiGirish1
 
Corrective and Preventive Actions
Corrective and Preventive Actions Corrective and Preventive Actions
Corrective and Preventive Actions
Willie Carter
 
Understanding and implementing quality management system in medical laboratories
Understanding and implementing quality management system in medical laboratoriesUnderstanding and implementing quality management system in medical laboratories
Understanding and implementing quality management system in medical laboratories
PathKind Labs
 
Monitoring and evaluation
Monitoring and evaluationMonitoring and evaluation
Monitoring and evaluation
migom doley
 
Evaluation_Training.pptx
Evaluation_Training.pptxEvaluation_Training.pptx
Evaluation_Training.pptx
lovelampsys
 
Clinical effectiveness
Clinical effectivenessClinical effectiveness
Clinical effectiveness
Dr. Raheem Rajab MBBS, MBA, MSc
 
6333147 how-to-get-started-with-jci-accreditation
6333147 how-to-get-started-with-jci-accreditation6333147 how-to-get-started-with-jci-accreditation
6333147 how-to-get-started-with-jci-accreditation
youssefpec
 

Similar to Module 11 Process Improvement.pptx (20)

EMIS
EMIS EMIS
EMIS
 
ME_Katende (2).ppt
ME_Katende (2).pptME_Katende (2).ppt
ME_Katende (2).ppt
 
Assessment MEAL Frameworks in scientific field.ppt
Assessment MEAL Frameworks in scientific field.pptAssessment MEAL Frameworks in scientific field.ppt
Assessment MEAL Frameworks in scientific field.ppt
 
Qi toolkit oct 2020
Qi toolkit oct 2020 Qi toolkit oct 2020
Qi toolkit oct 2020
 
9 Quality Management System_EAT G H 2021.pptx
9 Quality Management System_EAT G H 2021.pptx9 Quality Management System_EAT G H 2021.pptx
9 Quality Management System_EAT G H 2021.pptx
 
Quality assurance
Quality assuranceQuality assurance
Quality assurance
 
monitoring and evaluation
monitoring and evaluationmonitoring and evaluation
monitoring and evaluation
 
Unit IV_Monitoring_and_Evaluation.pptx
Unit IV_Monitoring_and_Evaluation.pptxUnit IV_Monitoring_and_Evaluation.pptx
Unit IV_Monitoring_and_Evaluation.pptx
 
Quality assurance
Quality assuranceQuality assurance
Quality assurance
 
PLCO_Indicators_0606.pptx
PLCO_Indicators_0606.pptxPLCO_Indicators_0606.pptx
PLCO_Indicators_0606.pptx
 
Auditing for Sterile Production Area
Auditing for Sterile Production AreaAuditing for Sterile Production Area
Auditing for Sterile Production Area
 
Monitoring Scale-up of Health Practices and Interventions
Monitoring Scale-up of Health Practices and InterventionsMonitoring Scale-up of Health Practices and Interventions
Monitoring Scale-up of Health Practices and Interventions
 
Controlling ppt
Controlling  pptControlling  ppt
Controlling ppt
 
6_Kimberly Todd - QA and QC.pptx
6_Kimberly Todd - QA and QC.pptx6_Kimberly Todd - QA and QC.pptx
6_Kimberly Todd - QA and QC.pptx
 
Corrective and Preventive Actions
Corrective and Preventive Actions Corrective and Preventive Actions
Corrective and Preventive Actions
 
Understanding and implementing quality management system in medical laboratories
Understanding and implementing quality management system in medical laboratoriesUnderstanding and implementing quality management system in medical laboratories
Understanding and implementing quality management system in medical laboratories
 
Monitoring and evaluation
Monitoring and evaluationMonitoring and evaluation
Monitoring and evaluation
 
Evaluation_Training.pptx
Evaluation_Training.pptxEvaluation_Training.pptx
Evaluation_Training.pptx
 
Clinical effectiveness
Clinical effectivenessClinical effectiveness
Clinical effectiveness
 
6333147 how-to-get-started-with-jci-accreditation
6333147 how-to-get-started-with-jci-accreditation6333147 how-to-get-started-with-jci-accreditation
6333147 how-to-get-started-with-jci-accreditation
 

More from Fatima Fasih

Zoonotic infections.ppt
Zoonotic infections.pptZoonotic infections.ppt
Zoonotic infections.ppt
Fatima Fasih
 
SIRS.ppt
SIRS.pptSIRS.ppt
SIRS.ppt
Fatima Fasih
 
IMMUNE ENVASION BY MICROBES.pptx
IMMUNE ENVASION BY MICROBES.pptxIMMUNE ENVASION BY MICROBES.pptx
IMMUNE ENVASION BY MICROBES.pptx
Fatima Fasih
 
introduction to mycology (1).ppt
introduction to mycology (1).pptintroduction to mycology (1).ppt
introduction to mycology (1).ppt
Fatima Fasih
 
diagnosticmicrobiology-140523042250-phpapp01.pdf
diagnosticmicrobiology-140523042250-phpapp01.pdfdiagnosticmicrobiology-140523042250-phpapp01.pdf
diagnosticmicrobiology-140523042250-phpapp01.pdf
Fatima Fasih
 
diagnosinginfectiousdiseases-140317090826-phpapp01.pdf
diagnosinginfectiousdiseases-140317090826-phpapp01.pdfdiagnosinginfectiousdiseases-140317090826-phpapp01.pdf
diagnosinginfectiousdiseases-140317090826-phpapp01.pdf
Fatima Fasih
 
Overview of infectious diseases.pptx
Overview of infectious diseases.pptxOverview of infectious diseases.pptx
Overview of infectious diseases.pptx
Fatima Fasih
 
Pulmonary Infection (2).pptx
Pulmonary Infection (2).pptxPulmonary Infection (2).pptx
Pulmonary Infection (2).pptx
Fatima Fasih
 
Water bacteriology
Water bacteriologyWater bacteriology
Water bacteriology
Fatima Fasih
 

More from Fatima Fasih (9)

Zoonotic infections.ppt
Zoonotic infections.pptZoonotic infections.ppt
Zoonotic infections.ppt
 
SIRS.ppt
SIRS.pptSIRS.ppt
SIRS.ppt
 
IMMUNE ENVASION BY MICROBES.pptx
IMMUNE ENVASION BY MICROBES.pptxIMMUNE ENVASION BY MICROBES.pptx
IMMUNE ENVASION BY MICROBES.pptx
 
introduction to mycology (1).ppt
introduction to mycology (1).pptintroduction to mycology (1).ppt
introduction to mycology (1).ppt
 
diagnosticmicrobiology-140523042250-phpapp01.pdf
diagnosticmicrobiology-140523042250-phpapp01.pdfdiagnosticmicrobiology-140523042250-phpapp01.pdf
diagnosticmicrobiology-140523042250-phpapp01.pdf
 
diagnosinginfectiousdiseases-140317090826-phpapp01.pdf
diagnosinginfectiousdiseases-140317090826-phpapp01.pdfdiagnosinginfectiousdiseases-140317090826-phpapp01.pdf
diagnosinginfectiousdiseases-140317090826-phpapp01.pdf
 
Overview of infectious diseases.pptx
Overview of infectious diseases.pptxOverview of infectious diseases.pptx
Overview of infectious diseases.pptx
 
Pulmonary Infection (2).pptx
Pulmonary Infection (2).pptxPulmonary Infection (2).pptx
Pulmonary Infection (2).pptx
 
Water bacteriology
Water bacteriologyWater bacteriology
Water bacteriology
 

Recently uploaded

Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
Peter Windle
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Dr. Vinod Kumar Kanvaria
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
Vivekanand Anglo Vedic Academy
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
Nguyen Thanh Tu Collection
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdfMASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
goswamiyash170123
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
The Diamond Necklace by Guy De Maupassant.pptx
The Diamond Necklace by Guy De Maupassant.pptxThe Diamond Necklace by Guy De Maupassant.pptx
The Diamond Necklace by Guy De Maupassant.pptx
DhatriParmar
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
Jean Carlos Nunes Paixão
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
SACHIN R KONDAGURI
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
Peter Windle
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
heathfieldcps1
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 
Digital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion DesignsDigital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion Designs
chanes7
 

Recently uploaded (20)

Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdfMASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
The Diamond Necklace by Guy De Maupassant.pptx
The Diamond Necklace by Guy De Maupassant.pptxThe Diamond Necklace by Guy De Maupassant.pptx
The Diamond Necklace by Guy De Maupassant.pptx
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 
Digital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion DesignsDigital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion Designs
 

Module 11 Process Improvement.pptx

  • 1. Session 11: Process Improvement Dr. Shree Baboolal 2/4/2023 1
  • 2. Process Improvement – Role in QMS • Process Improvement – establishes a program for helping to ensure continual improvement in the lab over time. • Continual improvement of the lab processes is essential in a QMS. 2/4/2023 Infectious Disease Detection and Surveillance (IDDS) 2
  • 3. W. Edward Deming • Guru of Process Improvement. • Deming Plan-Do-Check-Act (PDCA) shows how to achieve continual improvement in any process. 2/4/2023 Infectious Disease Detection and Surveillance (IDDS) 3
  • 4. PDCA • Plan – • Identify the problems and the potential sources of system weakness or error. • Decide on the steps to be used to gather information. • Ask the question “How can you best assess the current situation and analyze root causes of problem areas?” • Using the information that is gathered through these techniques, develop a plan for improvement. • Do – • Implement whatever plans have been developed. • Put the plan in action. 2/4/2023 Infectious Disease Detection and Surveillance (IDDS) 4
  • 5. PDCA • Check – • Refers to the monitoring process. • It is important to assess the effectiveness of the actions taken. • This is done using focused review and audit process. • After checking, revise the plan as required to achieve the improvements needed. • Act – • Take any corrective action that is required and then recheck to be sure that the solution has worked. • This cycle is a continuous process, so the lab will begin again with a planning process to continue the improvements. 2/4/2023 Infectious Disease Detection and Surveillance (IDDS) 5
  • 6. ISO 15189 and Continual Improvements • Activities for achieving continual improvements in the laboratory: • Identify potential sources of any system weakness or error. • Develop plans to implement improvement • Implement the plan • Review the effectiveness of the action through the process of focused review and audit. • Adjust the action plan and modify the system in accordance with the review and adjust results. 2/4/2023 Infectious Disease Detection and Surveillance (IDDS) 6
  • 7. What is Process Improvement? • What is process improvement? • Systematic and periodic approach to improving lab quality. • In the lab patient samples are turned into results through processes. • In process improvement – these processes are reviewed and improved to ensure quality. 2/4/2023 Infectious Disease Detection and Surveillance (IDDS) 7
  • 8. Tools for Process Improvement • Internal and External Audits • Identify system weakness and problem areas. • Participation in EQA • Allows for comparing laboratory performance to that of other laboratories. • Management Review • Reviews of records such as QC, inventory management, equipment managements etc. • Review of Quality Indicators • Customer complaints, TATs, errors etc. 2/4/2023 Infectious Disease Detection and Surveillance (IDDS) 8
  • 9. Quality Indicators • Established measures used to determine how well an organization meets needs and operational performance expectations. • ISO15189 states that the lab SHALL implement quality indicators to systematically monitor and evaluate the lab’s contribution to patient care. • When OFIs are identified the lab management SHALL address them regardless of where they occur. • ISO 15189 also states that labs participate in quality improvement activities that deals with patient care. 2/4/2023 Infectious Disease Detection and Surveillance (IDDS) 9
  • 10. Quality Indicators • Quality Indicators are information that is measured. The indicators: • Give information about the performance of a process • Determine quality of service • Highlight potential quality concerns • Identify areas that need further study and investigation • Track changes over time. 2/4/2023 Infectious Disease Detection and Surveillance (IDDS) 10
  • 11. Selecting quality indicators • Fewer are better. • Too many may make it difficult to track • Link the indicators to the factors needed for success. • Choose the quality indicators that relate to areas that need correction in order to achieve good performance. • Select those that will be most meaningful to the laboratory. • Indicators should be around customers and stakeholders needs. 2/4/2023 Infectious Disease Detection and Surveillance (IDDS) 11
  • 12. Selecting Quality Indicators • Measures should look at all levels of the laboratory. • Include indicators that will evaluate function at the top management level, but also flow down to all levels of employees. • Measures should change as the environment and strategy changes. • Do not stick with the same indicators over long periods of time. • Base the targets and goals for the measures on rational values, rather than values of convenience. • They should be established on the basis of research rather than arbitrary estimates. 2/4/2023 Infectious Disease Detection and Surveillance (IDDS) 12
  • 13. Developing Successful Quality Indicators • When developing successful quality indicators, ensure the following: • Objective: • Indicators should be measurable – usually in % or numbers e.g. contamination rate >2% • Should not depend on subjective judgements • Concrete evidence that the event occurred or not – e.g. number of errors • The target is clearly met – e.g. if the target for successful PT is 80% or more. • Methodology available: • Be sure that the organization has the tools needed to accomplish the necessary measurements. • The laboratory must have the ability to gather the information. • If the data or information collection requires special equipment, then make sure the special equipment is available before starting. 2/4/2023 Infectious Disease Detection and Surveillance (IDDS) 13
  • 14. Developing Successful Quality Indicators • When developing successful quality indicators, ensure the following: • Limits: • The laboratory will need to know the acceptable value before starting measurements. • Determine in advance the limits of acceptability, and at what point a result causes concern. • Also consider what action will be required. For example, how many delayed reports per month would be considered acceptable? How many would be considered as requiring corrective actions? How many would require immediate revision of the action plan? • Interpretation: • Decisions must be made as to how indicator information will be interpreted before beginning measurements. • Know in advance how to interpret the information that has been collected. For example, if you are monitoring completed requisitions to see if they are correct, you need to know how many samples you have examined, if they have come from multiple sources or all sources, and whether they are for only one type of sample or all sample types. 2/4/2023 Infectious Disease Detection and Surveillance (IDDS) 14
  • 15. Developing Successful Quality Indicators • When developing successful quality indicators, ensure the following: • Limitation: • The organization should understand exactly what information is being provided by the indicator, and be clear on what is not being determined by the measurement of a particular indicator. • For example, if collecting the number of accidents or errors, do you know if all are being reported? • Presentation: • The organization must decide how to present the information in order to fully display its value. • Some information is best presented in a table, whereas other information might be best shown by a longitudinal graphic bar or in text. • Presentation of information is important when looking for trends that predict future outcome. 2/4/2023 Infectious Disease Detection and Surveillance (IDDS) 15
  • 16. Developing Successful Quality Indicators • When developing successful quality indicators, ensure the following: • Action Plan: • Before beginning the use of an indicator, the laboratory should have some idea of what to do if the indicator shows that there is a problem. • Also decide how to collect the information, who will collect it, and how long it will be collected. • Exit Plan: • Because making these measurements takes time and resources, there should be a plan as to when to stop using a particular indicator and replace it with another. • Generally, this is done when the original indicator shows that the operation is working and stable. 2/4/2023 Infectious Disease Detection and Surveillance (IDDS) 16
  • 17. Characteristics of Good QIs • Measurable – evidence can be gathered and counted. • Achievable – the lab has the capacity to gather the evidence • Interpretable – information can be used to make decisions • Actionable – it is possible to do something about it • Balanced – in all phases of testing • Engaging – should examine work of all staff and not just selected staff • Timed – consider short and long term implications 2/4/2023 Infectious Disease Detection and Surveillance (IDDS) 17
  • 18. Common Indicators tracked 2/4/2023 Infectious Disease Detection and Surveillance (IDDS) 18
  • 19. Implementing Process Improvements • Essential factors and steps: • Commitment from all levels of the lab staff. • Careful planning so that goals can be achieved. • An organizational structure that supports process improvements. • Leadership. • Engagement of the people who normally do the tests 2/4/2023 Infectious Disease Detection and Surveillance (IDDS) 19
  • 20. Quality Improvement Activities • Use a timeline and do not take on more than can be accomplished within a timeframe. • Use a team approach involving bench level staff. • Use appropriate quality improvement tools. • Implement corrective and preventive actions. • Report quality improvement findings and corrective action progress to management and staff. 2/4/2023 Infectious Disease Detection and Surveillance (IDDS) 20